Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi

June 9, 2011 By Bio-Medicine.Org

IRVINE, Calif. and OXFORD, Miss., June 9, 2011
/PRNewswire/ — ChromaDex Corp. (OTCBB: CDXC) and the
University of Mississippi today announced the university has
granted the natural products company the exclusive worldwide patent
rights to a potential new therapeutic use for pterostilbene
(tero-STILL-bean) as an anxiolytic or anti-anxiety agent.
ChromaDex’ pTeroPure® is an ultra-pure formulation of
pterostilbene, a compound found in blueberries and demonstrated to
have multiple health benefits.

ChromaDex continues its strategy of expanding its intellectual
property supporting pterostilbene as the company builds its
pTeroPure product portfolio and seeks partnerships to enter new
markets. ChromaDex previously licensed two patents from the
University of Mississippi that focus on the ability of
pterostilbene to reduce blood lipoprotein levels and
pterostilbene’s effect on oxidative stress and cognition. ChromaDex
also holds rights to patents related to manufacturing claims.

“Adding the anxiolytic indication to our existing patent
portfolio around pTeroPure allows us to capitalize on new product
opportunities that we can pursue independently or with partners
looking to differentiate their own products,” said ChromaDex
President William Spengler. “ChromaDex will continue to seek
partners such as the University of Mississippi so as to capture
advancements in natural product research that will allow us to
provide the marketplace with innovative proprietary
ingredients.”

Research conducted by the University of Mississippi School of
Pharmacy shows pterostilbene may have anxiolytic activities. The
researchers determined pterostilbene activates the ERK signaling
pathway in the hippocampus, an area of the brain speculated to play
a role in anxiety. The effect of pterostilbene was investigated in
a classic animal model of anxiety and found to be comparable in
activity to the anti-anxiety drug diazepam used as the control drug
in the mod

‘/>”/>

SOURCE

Related Articles Read More >

CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech